Temozolomide and olaparib for the treatment of an ARID1A-mutated uterine carcinosarcoma: A case report.

Liu C, Abozenah Y, Rutherford TJ, Andikyan V, Kohut A, Anderson ML

DOI: 10.1016/j.gore.2026.102210
Published: 2026 Oct
Container: Gynecologic oncology reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.gore.2026.102210,
  title = {Temozolomide and olaparib for the treatment of an ARID1A-mutated uterine carcinosarcoma: A case report.},
  author = {Liu C and Abozenah Y and Rutherford TJ and Andikyan V and Kohut A and Anderson ML},
  year = {2026},
  journal = {Gynecologic oncology reports},
  doi = {10.1016/j.gore.2026.102210},
  url = {https://doi.org/10.1016/j.gore.2026.102210}
}

RIS

TY  - JOUR
TI  - Temozolomide and olaparib for the treatment of an ARID1A-mutated uterine carcinosarcoma: A case report.
AU  - Liu C
AU  - Abozenah Y
AU  - Rutherford TJ
AU  - Andikyan V
AU  - Kohut A
AU  - Anderson ML
PY  - 2026
JO  - Gynecologic oncology reports
DO  - 10.1016/j.gore.2026.102210
UR  - https://doi.org/10.1016/j.gore.2026.102210
ER  -

APA

C, L., Y, A., TJ, R., V, A., A, K., & ML, A. (2026). Temozolomide and olaparib for the treatment of an ARID1A-mutated uterine carcinosarcoma: A case report.. Gynecologic oncology reports. https://doi.org/10.1016/j.gore.2026.102210

Source records

pubmed · retrieved 2026-09-25T12:12:45.446Z